Core Viewpoint - Oshkosh (OSK) has been upgraded to a Zacks Rank 1 (Strong Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [4]. Company Performance and Outlook - The upgrade for Oshkosh indicates an improvement in the company's underlying business, which is expected to drive the stock price higher as investors recognize this trend [5][10]. - For the fiscal year ending December 2025, Oshkosh is projected to earn $10.93 per share, with a 7.6% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7][9]. - The upgrade of Oshkosh to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].

Group 1 - VAREX IMAGING (VREX) shares have increased by 53.7% in the past four weeks, closing at $11.45, with a mean price target of $16.75 indicating a potential upside of 46.3% [1] - The average price targets range from a low of $10.00 to a high of $23.00, with a standard deviation of $5.38, suggesting variability in analyst estimates [2] - Analysts have shown strong agreement in revising earnings estimates higher, with a 59.5% increase in the Zacks Consensus Estimate for the current year, indicating positive earnings prospects [11][12] Group 2 - VREX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] - While price targets can be misleading, the direction implied by the consensus price target appears to be a useful guide for potential price movement [14]

Core Viewpoint - Payoneer Global Inc. (PAYO) shows potential for significant upside, with a mean price target of $9.56 indicating a 41.4% increase from its current price of $6.76 [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $1.67, suggesting variability in analyst predictions [2] - The lowest estimate is $7.00, indicating a 3.6% increase, while the highest estimate is $12.00, suggesting a 77.5% increase [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Consensus - Analysts are optimistic about PAYO's earnings prospects, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [11] - Over the last 30 days, three earnings estimates have been revised upward, leading to a 6% increase in the Zacks Consensus Estimate [12] - PAYO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are a common tool for investors, they can often mislead, and reliance solely on them may not yield favorable returns [3][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Shares of Loar Holdings Inc. (LOAR) have gained 1.1% over the past four weeks to close the last trading session at $72.45, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $95.25 indicates a potential upside of 31.5%.The mean estimate comprises four short-term price targets with a standard deviation of $4.99. While the lowest estimate of $90.00 indicates a 24.2% increase from the ...

Core Viewpoint - Enliven Therapeutics, Inc. (ELVN) shows significant upside potential with a mean price target of $41.13, indicating a 102.4% increase from its current trading price of $20.32 [1][2]. Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $6.66, suggesting variability in analyst predictions. The lowest estimate is $33.00 (62.4% increase), while the highest is $52.00 (155.9% increase) [2]. - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Optimism - Analysts have shown growing optimism regarding ELVN's earnings prospects, as evidenced by a positive trend in earnings estimate revisions. The Zacks Consensus Estimate for the current year has increased by 5.3% over the last 30 days, with two estimates moving higher and no negative revisions [11][12]. - ELVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [13]. Caution on Price Targets - While price targets are often sought after by investors, they can be misleading. Empirical research suggests that price targets rarely indicate actual stock price movements, and analysts may set overly optimistic targets due to business incentives [7][8][10].

Core Viewpoint - Avadel (AVDL) shares have increased by 39.7% in the past four weeks, closing at $14.85, with a mean price target of $19 indicating a potential upside of 28% [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $2.88, where the lowest estimate is $16.00 (7.7% increase) and the highest is $24.00 (61.6% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising AVDL's earnings estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, four earnings estimates have been revised upward, leading to a 39.4% increase in the Zacks Consensus Estimate [12] Zacks Rank and Investment Potential - AVDL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting gains, they can indicate the direction of price movement [14]

Core Viewpoint - Applied Digital Corporation (APLD) has shown a significant price increase of 50.8% over the past four weeks, with a mean price target of $20 indicating a potential upside of 25.4% from the current price of $15.95 [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $5.39, indicating variability among analysts [2] - The lowest estimate is $13.00, suggesting an 18.5% decline, while the highest estimate is $30.00, indicating an 88.1% potential increase [2] - A low standard deviation signifies a strong agreement among analysts regarding the stock's price direction [9] Earnings Estimates and Analyst Agreement - Analysts have shown strong agreement in revising APLD's earnings estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 8.2% over the past month, with two estimates increasing and one decreasing [12] - APLD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on price targets for investment decisions may not be prudent, as analysts' price targets can often be overly optimistic due to business incentives [8][10] - Despite the skepticism surrounding price targets, the direction they imply can serve as a useful guide for further research [14]

Group 1 - Tidewater (TDW) closed at $59.8, with a 13% gain over the past four weeks, and a mean price target of $76 indicates a 27.1% upside potential [1] - The mean estimate includes five short-term price targets with a standard deviation of $19.79, ranging from a low of $55.00 (8% decline) to a high of $108.00 (80.6% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements [11][12] Group 2 - The Zacks Consensus Estimate for the current year has increased by 15% over the last 30 days, with no negative revisions [12] - TDW holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be reliable for exact gains, it suggests a positive direction for price movement [14]

Group 1 - Omnicell (OMCL) closed at $33.09, with a 14.1% gain over the past four weeks, and a mean price target of $44.4 indicating a 34.2% upside potential [1] - The average price targets range from a low of $34.00 to a high of $55.00, with a standard deviation of $9.13, suggesting variability in analyst estimates [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 33.6% over the past month, with three estimates going higher and no negative revisions [12] - OMCL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement [14]

Group 1 - Archrock Inc. (AROC) shares have increased by 3.1% over the past four weeks, closing at $24.02, with a mean price target of $31.13 indicating a potential upside of 29.6% [1] - The average of eight short-term price targets ranges from a low of $30.00 to a high of $33.00, with a standard deviation of $0.99, suggesting a consensus among analysts [2] - Analysts are optimistic about AROC's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has historically correlated with stock price movements [4][11] Group 2 - Over the last 30 days, two earnings estimates for AROC have been revised upward, leading to a 4.9% increase in the Zacks Consensus Estimate for the current year [12] - AROC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While the consensus price target may not be a reliable indicator of the magnitude of AROC's gains, it does provide a directional guide for potential price movement [14]